Washington University School of Medicine in St. Louis, Denali Therapeutics deal

Denali partnered with Washington University School of Medicine to develop and commercialize antibodies targeting apolipoprotein E (APOE), a genetic risk factor for Alzheimer’s disease (AD). Washingto...